CanadaTeva-Pregabalin 150 mg capsules (DIN 02361205) from lots 100070495 and 100068913, expiry July 31, 2027, sold in Canada, can be identified by those lot numbers and expiry. They were recalled after testing found possible contamination with the drug sertraline, which could cause side effects or serious allergic reactions including anaphylaxis. If you have a severe allergic reaction stop taking the product and call 9-1-1; otherwise do not stop without speaking to your healthcare professional and return the product to the pharmacy for replacement or disposal.
How to identify it
Product: Teva-Pregabalin 150 mg capsules; DIN: 02361205; Lot: 100070495 100068913; Expiry: July 31, 2027
The hazard
Teva Canada Ltd. is recalling two lots of Teva-Pregabalin 150 mg capsules after routine testing identified that some capsules may be contaminated with the drug sertraline. Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure.
Anaphylactic reaction symptoms can be fatal and may include:
Shortness of breath, wheezing, or difficulty breathing
Swelling of the eyelids, face, lips, mouth, tongue, or throat
Uncontrolled shaking
Fainting or dizziness
Trouble swallowing or speaking
Widespread rash, hives
Products from the recalled lots were first sold in Canada in September 2025 and expire July 31, 2027.
Pregabalin is a prescription drug used in adults to treat pain caused by nerve damage due to diabetes, shingles or spinal cord injury. It is also used to treat pain associated with fibromyalgia.
Sertraline is a prescription drug used in adults to relieve symptoms of depression, obsessive-compulsive disorder, and panic disorder. Side effects may include nausea, diarrhea, dry mouth, sleep changes, dizziness, tremors or increased sweating.
Health Canada is monitoring the company's recall and implementation of corrective and preventive actions.
What to do
If you experience a serious allergic reaction (anaphylaxis), stop taking the affected product and seek immediate medical help by calling 9-1-1. Otherwise, do not stop taking your pregabalin medication without first speaking with your healthcare professional or pharmacist, as stopping suddenly may cause withdrawal symptoms including insomnia, nausea, headache, anxiety, excessive sweating, diarrhea, and convulsions.
Return the product to the pharmacy where it was purchased as soon as possible for a replacement or alternative supply, and for proper disposal. If you are unsure whether your product is recalled, check with your pharmacy.
Seek medical attention if you have used this product and think you are experiencing side effects.
Contact Teva Canada Customer Care by calling toll-free at 1-800-268-4129 or by email at customer.service@tevacanada.com, if you have questions about this recall.
Report any health product-related side effects or complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)